PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non‑small cell lung cancer
Chun'an Bian(Nanjing Medical University), Lifeng Zhen(Nantong University)
Cited by 33
Related Papers
Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
|World Journal of Surgical Oncology|2015|23